LexDanaLexDanabeta
Inventor

MARLA DUBINSKY

Inventor
US

Overview

2→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms50%
PatentTitleYear
12,084,722Methods of determining responsiveness to anti-TNFa therapy in inflammatory bowel disease202411,236,393Methods of determining responsiveness to anti-TNFa therapy in inflammatory bowel disease2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to CEDARS SINAI MEDICAL CENTER (2)· patent assignee history
2022–2024Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CEDARS SINAI MEDICAL CENTER22022–2024
Locations
LocationPatentsSpan
US22022–2024